Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Lars E. Rutqvist & Hemming Johansson. (2007) Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer. Acta Oncologica 46:2, pages 133-145.
Read now
Read now
Lars E. Rutqvist & Hemming Johansson. (2006) Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among ‘high risk’ pre- and postmenopausal breast cancer patients. Acta Oncologica 45:5, pages 517-527.
Read now
Read now
Mårten Fernö, Christina Andersson, Ghita Fallenius & Ingrid Idvall. (1996) Oestrogen Receptor Analysis of Paraffin Sections and Cytosol Samples of Primary Breast Cancer in Relation to Outcome After Adjuvant Tamoxifen Treatment. Acta Oncologica 35:1, pages 17-22.
Read now
Read now
Agneta Bergqvist, David Bergqvist & Mårten Fernö. (1993) Estrogen and progesterone receptors in vessel walls: Biochemical and immunochemical assays. Acta Obstetricia et Gynecologica Scandinavica 72:1, pages 10-16.
Read now
Read now
Olle Stål, Ann Brisfors, John Carstensen, Lilianne Ferraud & Thomas Hatschek. (1992) Interrelations Between Cellular DNA Content, S-Phase Fraction, Hormone Receptor Status and Age in Primary Breast Cancer A Series of 1 342 Consecutively Detected Tumors. Acta Oncologica 31:3, pages 283-292.
Read now
Read now
MÅRten Fernö, Bo Baldetorp, ÅKe Borg, HÅKan Olsson, Helgi Sigurdsson & Dick Killander. (1992) Flow Cytometric DNA Index and S-Phase Fraction in Breast Cancer in Relation to Other Prognostic Variables and to Clinical Outcome. Acta Oncologica 31:2, pages 157-165.
Read now
Read now
J. Johansson, L. Thulin, M. Fernoü & å. Andrén-Sandbrrg. (1991) Correspondence and Short Communications: Estrogen Receptors in Gastric Cancer. Acta Oncologica 30:7, pages 870-872.
Read now
Read now
M. Fernö, Å. Borg, U. Johansson, A. Norgren, H. Olsson, S. Rydén & G. Sellberg. (1990) Estrogen and Progesterone Receptor Analyses in More Than 4000 Human Breast Cancer Samples: A Study with Special Reference to Age at diagnosis and stability of analyses. Acta Oncologica 29:2, pages 129-135.
Read now
Read now
L. E. Rutqvist. (1990) The Significance of Hormone Receptors to Predict the Endocrine Responsiveness of Human Breast Cancer. Acta Oncologica 29:3, pages 371-377.
Read now
Read now
A. Borg, M. Ferno & I. Idvall. (1989) Estrogen Receptor Enzyme Immunoassay in Fine-Needle Aspirates from Human Breast Cancer. Acta Oncologica 28:2, pages 187-191.
Read now
Read now
M. Fernö, A. Borg & U. Johansson. (1989) Enzyme Immunoassay of Progesterone Receptor in Breast Cancer Biopsy Samples A comparison with the dextran coated charcoal method. Acta Oncologica 28:1, pages 19-22.
Read now
Read now
N. Wilking, L. E. Rutqvist, B. Nordenskjöld & L. Skoog. (1989) Steroid Receptor Levels in Breast Cancer: Relationships with Age and menopausal status. Acta Oncologica 28:6, pages 807-810.
Read now
Read now
Articles from other publishers (17)
Anna Ehinger, Pär-ola Bendahl, Lisa Rydén, Mårten Fernö & Sara Alkner. (2018) Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time. APMIS 126:9, pages 746-754.
Crossref
Crossref
Marie Sundquist, Lars Brudin & Göran Tejler. (2017) Improved survival in metastatic breast cancer 1985–2016. The Breast 31, pages 46-50.
Crossref
Crossref
Josefine Bostner, Elin Karlsson, Cecilia Bivik Eding, Gizeh Perez-Tenorio, Hanna Franzén, Aelita Konstantinell, Tommy Fornander, Bo Nordenskjöld & Olle Stål. (2015) S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts. Endocrine-Related Cancer 22:3, pages 331-343.
Crossref
Crossref
Mahmoud R. Khoshnoud, Britta Löfdahl, Helena Fohlin, Tommy Fornander, Olle Stål, Lambert Skoog, Jonas Bergh & Bo Nordenskjöld. (2010) Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen. Breast Cancer Research and Treatment 126:2, pages 421-430.
Crossref
Crossref
Mahmoud R. Khoshnoud, Tommy Fornander, Hemming Johansson & Lars-Erik Rutqvist. (2007) Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen. Breast Cancer Research and Treatment 107:1, pages 71-78.
Crossref
Crossref
Mårten Fernö, Olle Stål, Bo Baldetrop, Thomas Hatschek, Ann-Christine Källström, Per Malmström, Bo Nordenskjöld & Stefan Rydén. (2000) Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. Breast Cancer Research and Treatment 59:1, pages 69-76.
Crossref
Crossref
H Jernström, J Frenander, M Fernö & H Olsson. (1999) Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. British Journal of Cancer 80:9, pages 1453-1458.
Crossref
Crossref
Pascal Pujol, Jean-Pierre Daures, Simon Thezenas, Fan�oise Guilleux, Phillipe Rouanet & Jean Grenier. (1998) Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause. Cancer 83:4, pages 698-705.
Crossref
Crossref
Niklas Loman, Oskar Johannsson, P�r-Ola Bendahl, �ke Borg, M�rten Fern� & H�kan Olsson. (1998) Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83:2, pages 310-319.
Crossref
Crossref
M�rten Fern�, Bo Baldetorp, P�r-Ola Bendahl, �ke Borg, Sven-B�rje Ewers, H�kan Olsson, Stefan Ryd�n, Helgi Sigurdsson & Dick Killander. (1995) Recurrence-free survival in breast cancer improved by adjuvant tamoxifen -especially for progesterone receptor positive tumors with a high proliferation. Breast Cancer Research and Treatment 36:1, pages 23-34.
Crossref
Crossref
Åke Borg, Qiu-Xia Zhang, Håkan Olsson & Eva Wenngren. (1992) Chromosome I alterations in breast cancer: Allelic loss on Ip and Iq Is related to lymphogenic metastases and poor prognosis. Genes, Chromosomes and Cancer 5:4, pages 311-320.
Crossref
Crossref
Olle Stål, Ann Brisfors, John Carstensen, Lilianne Ferraud, Thomas Hatschek & Bo Nordenskjöld. (2006) Relationships of DNA ploidy, S‐phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. International Journal of Cancer 51:1, pages 28-33.
Crossref
Crossref
A. Bergqvist. 1991. Modern Approaches to Endometriosis. Modern Approaches to Endometriosis
33
55
.
S. Marsigliante, J.R. Puddefoot, S. Barker, J. Gledhill & G.P. Vinson. (1990) Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples. The Journal of Steroid Biochemistry and Molecular Biology 37:5, pages 643-648.
Crossref
Crossref
Lars E. Rutqvist, Björn Cedermark, Ulla Glas, Hemming Johansson, Sam Rotstein, Lambert Skoog, Anders Somell, Tolle Theve, Nils Wilking, Jutta Askergren & Marie-Louise Hjalmar. (1990) Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer. Cancer 66:1, pages 89-96.
Crossref
Crossref
Eva Von Schoultz, Roger Henriksson, Marie Bixo, Torbjörn Bäckström, Herbert Silfvenius & Nils Wilking. (1990) Sex steroids in human brain tumors and breast cancer. Cancer 65:4, pages 949-952.
Crossref
Crossref
Lars Erik Rutqvist, Björn Cedermark, Ulla Glas, Hemming Johansson, Bo Nordenskjöld, Lambert Skoog, Anders Somell, Tolle Theve, Sten Friberg & Jutta Askergren. (1987) The Stockholm trial on adjuvant tamoxifen in early breast cancer. Breast Cancer Research and Treatment 10:3, pages 255-266.
Crossref
Crossref